Journal of Genomics and Precision Medicine
CRISPR and Gene Editing
CRISPR and gene-editing technologies represent one of the most transformative advancements in modern genomics, enabling precise alterations to DNA sequences within living organisms. Using targeted molecular tools, scientists can add, remove, or modify specific genetic material to correct mutations, study gene function, or engineer new biological traits. CRISPR’s accuracy, efficiency, and affordability have accelerated breakthroughs in medicine, agriculture, and biotechnology. In clinical settings, gene editing holds promise for treating genetic disorders such as sickle cell disease, muscular dystrophy, and inherited blindness by directly repairing defective genes. Ongoing research explores its potential in cancer therapy, immune modulation, and infectious disease resistance. Despite its immense potential, ethical considerations and safety challenges remain critical areas of focus.
Article Processing Timeline
| 2-5 Days | Initial Quality & Plagiarism Check |
| 15 Days |
Peer Review Feedback |
| 85% | Acceptance Rate (after peer review) |
| 30-45 Days | Total article processing time |
Indexed In
ResearchBib
Sindexs
OAJI
DOAJ
CrossRef
PubMed
MEDLINE
EBSCO A-Z / Host
OCLC - WorldCat
Journal Flyer
